Displaying drugs 10376 - 10400 of 14740 in total
CVT-6883
CVT-6883 is a selective, potent and orally available A2B-adenosine receptor antagonist which CV Therapeutics is investigating for the potential treatment of asthma and other conditions related to inflammation and fibrosis.
Investigational
Matched Description: … and fibrosis. ... is investigating for the potential treatment of asthma and other conditions related to inflammation ... CVT-6883 is a selective, potent and orally available A2B-adenosine receptor antagonist which CV Therapeutics …
Carbomycin
Carbomycin, also called magnamycin, is crystalline macrolide antibiotic. This antibacterial is obtained from Streptomyces halstedii and it presents a large inhibitory effect against Gram-positive bacteria and some Mycoplasma strains. The structure of carbomycin was generated in 1957 by Robert Woodward and later modified in 1965.
Vet approved
Matched Description: … against Gram-positive bacteria and some Mycoplasma strains. ... The structure of carbomycin was generated in 1957 by Robert Woodward and later modified in 1965. ... This antibacterial is obtained from _Streptomyces halstedii_ and it presents a large inhibitory effect …
PCLX-001
PCLX-001 is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by Pacylex Pharmaceuticals (https://pacylex.com). Current studies have shown that PCLX-001 works differently than other known cancer drugs and has high activity and positive results in breast, lung, bladder and pancreas cancers.
Investigational
Matched Description: … activity and positive results in breast, lung, bladder and pancreas cancers. ... Current studies have shown that PCLX-001 works differently than other known cancer drugs and has high …
Lerodalcibep
Lerodalcibep is under investigation in clinical trial NCT05004675 (Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients).
Investigational
Matched Description: … of LIB003 and Inclisiran in High-risk CVD Patients). ... Lerodalcibep is under investigation in clinical trial NCT05004675 (Trial to Evaluate Efficacy and Safety …
Vatalanib
Vatalanib (PTK787/ZK-222584) is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors. Vatalanib is under investigation for the treatment of solid tumors.
Investigational
Mardepodect
Investigational
AZD-1305
AZD1305 has been used in trials studying the treatment and basic science of Atrial Flutter, Atrial Fibrillation, and Left Ventricle Function.
Investigational
Matched Description: … , and Left Ventricle Function. ... AZD1305 has been used in trials studying the treatment and basic science of Atrial Flutter, Atrial Fibrillation …
5-Hydroxymethylfurfural
Aes-103 has been used in trials studying the treatment and prevention of Hypoxia, Anemia, Sickle Cell, and Sickle Cell Disease.
Investigational
Matched Description: … , and Sickle Cell Disease. ... Aes-103 has been used in trials studying the treatment and prevention of Hypoxia, Anemia, Sickle Cell …
Bimiralisib
Bimiralisib is under investigation in clinical trial NCT02723877 (PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)).
Investigational
Matched Description: … Negative and Triple-negative Breast Cancer (PIQHASSO)). ... Bimiralisib is under investigation in clinical trial NCT02723877 (PQR309 and Eribulin in Metastatic HER2 …
1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL
Experimental
Human Umbilical Cord Mesenchymal Stem Cells
Stem cells obtained from amniotic fluid, the umbilical cord (UC), and placenta are gaining in popularity. Stem cells from the umbilical cord offer several advantages, including: non-invasive collection procedures, more hearty and steady growth than bone-marrow derived stem cells (they can maintain a steady doubling time (DT) over up to...
Investigational
Matched Description: … class II and its co-stimulatory ligands like CD40, CD80, and CD86. ... UC mesenchymal cells derived from Wharton’s jelly are the most studied and offer more stable and better ... osteogenic and adipogenic differentiation potentials. …
WIN 55212-2
WIN 55,212-2 is a chemical described as an aminoalkylindole derivative, which produces effects similar to those of cannabinoids such as tetrahydrocannabinol (THC) but has an entirely different chemical structure. It is a potent cannabinoid receptor agonist that has been found to be a potent analgesic in a rat model of...
Experimental
Matched Description: … It activates p42 and p44 MAP kinase via receptor-mediated signaling. …
Matched Categories: … Cannabinoids and similars ... Calcium-Regulating Hormones and Agents …
Matched Categories: … Cannabinoids and similars ... Calcium-Regulating Hormones and Agents …
3,5-Difluorobenzenesulfonamide
Experimental
3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid
Experimental
3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate
Experimental
Propentofylline
Investigational
Matched Categories: … Psychostimulants, Agents Used for ADHD and Nootropics …
2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE
Experimental
ADP-597
JNJ-38431055 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Investigational
Displaying drugs 10376 - 10400 of 14740 in total